Culture is currently considered the "gold standard" for detecting Chiamydia trachomatis infections. We evaluated the Syva MicroTrak enzyme immunoassay (EIA) and Gen-Probe PACE 2 tests, which detect chlamydial antigens and rRNA, respectively. These assays were compared with each other and with culture for the detection of C. trachomatis in cervical specimens obtained from 217 Chlamydia trachomatis is a major cause of sexually transmitted disease. In women, infection is frequently asymptomatic or may be associated with urethritis, mucopurulent cervicitis, and proctitis. The detection of these infections is important not only so that transmission to sexual partners and neonates can be reduced but also because untreated infections may progress to complications, including endometritis, salpingitis, and infertility (4, 12, 24, 27) . Laboratory tests are necessary to detect asymptomatic infections and to differentiate chlamydial infections from those caused by other microorganisms. Isolation in cell culture is considered the most sensitive and specific laboratory method for the diagnosis of chlamydial infections (1, 13, 24, 27) . However, culture is labor intensive, requires cold specimen transport, and takes up to 7 days to produce results. Thus, there is a need for sensitive and specific nonculture assays that make rapid and cost-effective screening possible. Several assays for the detection of chlamydial antigens by immunofluorescence (IF) and enzyme immunoassay (EIA) are currently available (1, 13, 27 and rRNA, respectively. These assays were compared with each other and with quantitative culture for the detection of cervical infection by C. trachomatis in a high-prevalence female population.
the probe assay. Quantitative evaluation of the results showed that false-negative results with either assay were associated with cultures that had low inclusion counts or were negative without subpassage. Analysis of nonculture results revealed that 2.3% of the EIA results and 4.6% of the probe assay results were within ±30%o of the respective assay cutoff values. These included four false-negative (one EIA and three probe) and two false-positive (one EIA and one probe) results. The Syva MicroTrak EIA and the Gen-Probe PACE 2 assay are comparable to but significantly less sensitive than culture. Use of a grey zone may help identify the need for repeat or confirmatory testing.
Chlamydia trachomatis is a major cause of sexually transmitted disease. In women, infection is frequently asymptomatic or may be associated with urethritis, mucopurulent cervicitis, and proctitis. The detection of these infections is important not only so that transmission to sexual partners and neonates can be reduced but also because untreated infections may progress to complications, including endometritis, salpingitis, and infertility (4, 12, 24, 27) . Laboratory tests are necessary to detect asymptomatic infections and to differentiate chlamydial infections from those caused by other microorganisms. Isolation in cell culture is considered the most sensitive and specific laboratory method for the diagnosis of chlamydial infections (1, 13, 24, 27) . However, culture is labor intensive, requires cold specimen transport, and takes up to 7 days to produce results. Thus, there is a need for sensitive and specific nonculture assays that make rapid and cost-effective screening possible. Several assays for the detection of chlamydial antigens by immunofluorescence (IF) and enzyme immunoassay (EIA) are currently available (1, 13, 27) . More recently, a nucleic acid hybridization assay that detects chlamydial rRNA has become available for diagnostic use (1) . EIA control preparation and then centrifuged for 1 h at 35°C at 2,500 x g. After centrifugation, 1.0 ml of Eagle's minimum essential medium containing 10% heat-inactivated fetal bovine serum, 30 mM glucose, antibiotics, and cycloheximide (1 ,ug/ml) was added to each vial, and the cultures were incubated at 35°C with 5% CO2. After 48 to 72 h, monolayers were fixed for 10 min with 95% ethanol, stained by using a fluorescein-conjugated genus-specific monoclonal antibody (Kallestad, Austin, Tex.), and examined at magnifications of x100 and x400 with a Nikon epifluorescence microscope (Nikon Inc., Melville, N.Y.). Cultures with one or more fluorescent inclusions were considered positive. The number of inclusions per coverslip was determined; specimens yielding low inclusion counts, i.e., 1 to 10, were examined by a second observer. Subpassage was performed by using the unstained duplicate vials of negative cultures and positive cultures with fewer than five inclusions.
Syva MicroTrak ETA. The Syva MicroTrak EIA was performed in accordance with the manufacturer's instructions. Briefly, specimen treatment solution (1.0 ml) was added to each specimen and control tube, and the tubes were placed in a heat block at 95 to 100°C for 15 min, cooled, and vortexed (15 s). Treated sample (100 pl) or control was added to a well of a microtiter plate containing 100 ,ul of rabbit anti-chlamydial lipopolysaccharide antibody. Following incubation for 90 min at 37°C and washing, 100 ,ul of peroxidase-labeled goat anti-rabbit immunoglobulin was added, and the mixture was incubated for 30 min at 37°C. After washing, 100 pl of substrate mixture (peroxide and TMB) was added to each well. Stop solution was added after incubation for 30 min at room temperature, and the A450s were read. Samples with absorbances equal to or greater than the cutoff value were considered positive.
Gen-Probe PACE 2. The chemiluminescent-probe assay utilizes an acridinium ester-labeled single-stranded DNA probe complementary to the rRNA of C. trachomatis and was performed in accordance with the manufacturer's instructions. Briefly, 100 p,l of the probe reagent was added to a tube containing 100 pl of vortexed (5 s) specimen or control and incubated for 1 h in a 60°C water bath. One milliliter of separation solution (containing metallic microbeads which bind hybridized probe) was added to each tube, and after incubation for 10 min at 60°C, the rack of tubes was placed on the magnetic separation base for 5 min at room temperature and the supernatants were decanted. Wash solution was added, and after 20 min at room temperature on the magnetic separation base, the supernatants were decanted and the relative light units (RLU) emitted by the chemiluminescent label were measured with a luminometer. Samples with an RLU valve equal to or greater than 300 plus the mean value obtained with the negative controls were considered positive.
Syva MicroTrak direct fluorescent-antibody assay. The residual EIA samples of culture-negative discordant specimens were tested by using the MicroTrak direct fluorescentantibody assay, which employs fluorescein-conjugated monoclonal antibodies to the species-specific major outer membrane protein. The sample residue was centrifuged for 15 min at 2,000 x g, the supernatant was removed, and 10 [lI 
RESULTS
Comparison of culture, ETA, and probe assay. C. trachomatis was detected by culture in 48 (22.1%) of 217 endocervical samples. Of these, 38 corresponding samples were positive by MicroTrak EIA, and 37 were positive by PACE 2 ( Table 1 ). There was a significant difference (P < 0.001) between culture and both nonculture assays. Three positive EIA and four positive probe results were obtained with specimens from patients with negative cultures. IF testing revealed elementary bodies in two of the three EIA-positive sample residues; of the four samples discrepant by probe, two were negative when the probe assay was repeated. The sensitivity and specificity compared with culture were 79.2 and 98.2%, respectively, for the MicroTrak EIA (Table 2) . When the two false-negative culture results are taken into account, the sensitivity increases to 80% and the specificity increases to 99.4%. With PACE 2, the sensitivity and specificity compared with culture were 77.1 and 97.6%, respectively, and the respective values when adjusted results are used increase to 78 and 98.8%.
Quantitative evaluation of results. Thirty-six specimen sets were positive and 164 sets were negative by all three methods. Inclusion counts were compared with absorbance (MicroTrak EIA) and RLU (PACE 2) values for the 36 concordant positive specimen sets (Table 3) . Twenty-six specimens (72%) yielded inclusion counts of greater than 1,000. Overall, specimens with higher inclusion counts had greater absorbance and RLU values in the corresponding samples. Five (2.3%) EIA and 10 (4.6%) PACE 2 results fell within ±30% of the respective assay cutoff value.
Analysis of discordant specimens. Seventeen specimen sets yielded discordant results (Table 4) . Of the five culturenegative discordant specimens, two were culture false negatives; corresponding samples were positive in both nonculture assays. Of the 12 culture-positive sets, false-negative results by either nonculture assay occurred primarily when corresponding specimens had low inclusion counts. One (10%) EIA and three (27%) PACE 2 false-negative results were within 30% of the respective assay cutoff value; 50% of the false negatives for each assay were within 60% of the respective cutoff value.
DISCUSSION
We have compared the Syva MicroTrak EIA and the Gen-Probe PACE 2 assay with culture for the diagnosis of cervical C. trachomatis infection in a high-prevalence female population. A previous study, which used isolation in McCoy cells in 96-well microtiter plates with subpassage as the reference method, showed a sensitivity of 89% and a specificity of 96% for the MicroTrak EIA with endocervical specimens obtained from a high-prevalence (14%) female population (9) . In five studies comparing PACE 2 with culture, the sensitivities for the probe assay ranged from 86.1 to 93% and the specificities ranged from 97.7 to 100% (12, (14) (15) (16) 28) . Several factors, including patient characteristics and infection prevalence (2, 8, 13, 17, 27) as well as differences in specimen collection (19) (24, 29) , and the subpassage of negative specimens has been shown to increase the number of chlamydial isolates by approximately 10% (25) . In this study, subpassage yielded five additional isolates. While it has been suggested that the order of sample collection may affect test results (7, 10) , our findings are consistent with those of other studies that have shown the swab order not to be a significant factor (3, 6, 20, 22) . Chi-square analysis showed that the swab order did not adversely affect the outcome of either nonculture assay (data not shown).
Our results included two specimens that were determined to be culture false negatives. While specific reasons could not be identified for these results, culture false negatives can occur as a result of technical failures, the presence of nonviable organisms, or the presence of inhibitory materials at the sampled site (13) . Culture false positives have been reported when immunoassays other than IF were used for culture confirmation (5) and when polymerase chain reaction was the reference method (14) . In this study, specimens with one or more stained intracytoplasmic inclusions were considered positive. Cultures with low inclusion counts were examined by a second observer; one specimen had fewer than five inclusions and was positive after subpassage.
We analyzed the results to determine whether the use of a grey zone would improve the diagnostic utility of the assays. Eight negative results (two by EIA and six by probe) fell within 30% of the cutoff value. While all corresponding samples were negative by the alternate direct assay, four (50%) were positive by culture. Seven positive results (three by EIA and four by probe) fell within the 30% grey zone. Of these, two EIA and three probe results were true positives. With EIA, 3 (27%) of the 11 false-negative results and the 1 false-positive result fell within the ±30% grey zone. Confirmatory IF testing of the EIA sample residue of the latter specimen was negative. With the probe assay, 4 (33%) of the 12 false-negative results and 1 of the 2 false-positive results fell within the +30% grey zone. Consistent with the suggestion to retest samples with low cutoff ratios in the probe assay (28) , both samples with false-positive results were negative when repeated. Others have shown that confirmatory (19) or supplemental (26) testing may improve the utility of nonculture chlamydial assays. Our results suggest that a grey zone may be useful for identifying specimens warranting repeat or confirmatory testing. Further evaluation is necessary to determine whether a different pattern will emerge with a lower-prevalence patient population. The Syva MicroTrak ETA and the Gen-Probe PACE 2 assay are comparable for the detection of cervical infections in a high-prevalence female patient population, with isolation in cell culture being significantly more sensitive than either nonculture assay. The EIA and the probe assay are useful for high-volume screening and can provide results with a shorter turnaround time than is possible for culture. With either assay, implementation of a grey zone appears useful for identifying the need for additional testing.
